Immunic, Inc. Announces Promotion of Glenn Whaley, CPA to Chief Financial Officer
NEW YORK, March 16, 2022 — Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical
NEW YORK, March 16, 2022 — Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical